NMLSF
Price:
$0.0622
Market Cap:
$3.61M
Restart Life Sciences Corp. is a biotechnology company, which engages in the research and development of psilocybin. It offers therapy and diagnostics for neuroinflammatory disorders. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
Industry
Biotechnology
IPO Date
2008-06-27
Stock Exchange
OTC
Ticker
NMLSF
According to Restart Life Sciences Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.44M. This represents a change of 233.64% compared to the average of 1.03M of the last 4 quarters.
The mean historical Enterprise Value of Restart Life Sciences Corp. over the last ten years is 130.16M. The current 3.44M Enterprise Value has changed 164.26% with respect to the historical average. Over the past ten years (40 quarters), NMLSF's Enterprise Value was at its highest in in the December 2017 quarter at 875.08M. The Enterprise Value was at its lowest in in the December 2024 quarter at 68.56K.
Average
130.16M
Median
66.20M
Minimum
985.72K
Maximum
720.72M
Discovering the peaks and valleys of Restart Life Sciences Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 954.79%
Maximum Annual Enterprise Value = 720.72M
Minimum Annual Increase = -96.64%
Minimum Annual Enterprise Value = 985.72K
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 985.72K | -96.64% |
| 2023 | 29.35M | -78.47% |
| 2022 | 136.30M | 123.85% |
| 2021 | 60.89M | -43.54% |
| 2020 | 107.85M | 68.31% |
| 2019 | 64.08M | -39.63% |
| 2018 | 106.13M | -85.27% |
| 2017 | 720.72M | 954.79% |
| 2016 | 68.33M | 881.85% |
| 2015 | 6.96M | 8.72% |
The current Enterprise Value of Restart Life Sciences Corp. (NMLSF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
55.54M
5-year avg
67.07M
10-year avg
130.16M
Restart Life Sciences Corp.’s Enterprise Value is greater than Algernon Pharmaceuticals Inc. (2.65M), less than Appili Therapeutics Inc. (14.26M), less than Ayala Pharmaceuticals, Inc. (7.85M), less than Universal Ibogaine Inc. (3.95M), greater than ReNeuron Group plc (-5684907.22), greater than Regen BioPharma, Inc. (1.32M), greater than Agentix Corp. (1.74M), greater than VG Life Sciences Inc. (2.11M), less than America Great Health (4.75M), greater than Health Sciences Group, Inc. (505.72K),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.65M | $1.92M | |
| 14.26M | $1.82M | |
| 7.85M | $4.41M | |
| 3.95M | $1.95M | |
| -5684907.22 | $62.89K | |
| 1.32M | $283.99K | |
| 1.74M | $1.71M | |
| 2.11M | $2.11M | |
| 4.75M | $2.12M | |
| 505.72K | $187.09K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Restart Life Sciences Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Restart Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Restart Life Sciences Corp.'s Enterprise Value?
What is the highest Enterprise Value for Restart Life Sciences Corp. (NMLSF)?
What is the 3-year average Enterprise Value for Restart Life Sciences Corp. (NMLSF)?
What is the 5-year average Enterprise Value for Restart Life Sciences Corp. (NMLSF)?
How does the current Enterprise Value for Restart Life Sciences Corp. (NMLSF) compare to its historical average?